Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.

about

Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study.Pitavastatin up-regulates eNOS production by suppressing miR-155 expression in lipopolysaccharide-stimulated human umbilical vein endothelial cells.

P2860

Q37685518-3CB29036-BCB3-40A5-98E5-E47047ADE60A Q47971584-3D9BB940-5820-4B45-B7C7-79C95C39F286

P2860

Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.

Item

http://www.wikidata.org/entity/Q38881481

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical benefits of pitavasta ...... t risk of developing diabetes.

@en

type

Item

label

Clinical benefits of pitavasta ...... t risk of developing diabetes.

@en

prefLabel

Clinical benefits of pitavasta ...... t risk of developing diabetes.

@en

P1476

Clinical benefits of pitavasta ...... t risk of developing diabetes.

@en

P2093

Carlos Escobar

http://www.w3.org/2001/XMLSchema#string

Vivencio Barrios

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study

Pitavastatin therapy in polymedicated patients is associated with a low risk of drug-drug interactions: analysis of real-world and phase 3 clinical trial data.

Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia.

[Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study].

Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia.

P304

449-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA-2016-0018

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27076402

http://www.w3.org/2001/XMLSchema#string

Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.

about

P2860

P2860

Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698